면역글로불린과 Leflunomide로 치료한 BK 바이러스 신병증 = Nephrology A Case of Combining Intravenous Immunoglobulin and Leflunomide for BK Nephropathy

다국어 초록 (Multilingual Abstract)

BK virus nephropathy has emerged as an important cause of renal allograft dysfunction. It affects 1-10% of renal transplant patients and results in significant graft dysfunction in more than 50% of cases. A reduction in the amount of immunosuppressants is not an appropriate treatment option for advanced stage BK nephropathy; therefore, other treatment strategies need to be considered such as cidofovir, leflunomide, and intravenous immunoglobulin (IVIG) in combination with reduced immunosuppression. The use of IVIG may be a valuable treatment option in patients with BK virus nephropathy. We report our experience with IVIG rescue therapy in a patient and the progression of BK nephropathy despite leflunomide therapy. (Korean J Med 2011;81:512-516)

참고문헌 (Reference)

1 손영기, "신장이식 후 BK 바이러스 관련 신병증에서의 leflunomide의 임상경험" 대한신장학회 28 (28): 211-218, 2009

2 Josephson MA, "Treatment of renal allograft polyoma BK virus infection with leflunomide" 81 : 704-710, 2006

3 Hirsch HH, "Polyomavirusassociated nephropathy in renal transplantation: interdisciplinary analyses and recommendations" 79 : 1277-1286, 2005

4 Binet I, "Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss" 67 : 918-922, 1999

5 Faguer S, "Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation" 20 : 962-969, 2007

6 Williams JW, "Leflunomide for polyomavirus type BK nephropathy" 352 : 1157-1158, 2005

7 Sener A, "Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients" 81 : 117-120, 2006

8 Waldman WJ, "Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide" 42 : 412-418, 1999

9 Brennan DC, "Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction" 5 : 582-594, 2005

10 Leca N, "Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients" 3 : 829-835, 2008

11 Lee JS, "Effect of high dose intravenous immunoglobulins on the treatment of antibody mediated humoral rejection and BK virus infection in renal transplant recipients" 21 : 140-142, 2007

12 Howell DN, "Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients" 68 : 1279-1288, 1999

13 Randhawa P, "BK virus infection in transplant recipients: an overview and update" 6 : 2000-2005, 2006